DLX3 and tricho-dento-osseous syndrome: Owing to the inhibition of osteogenic potential found in BMSCs isolated from the TDO patient or transgenic mice, the phenotype of increased bone mineral density is attributed to delayed cellular senescence caused by DLX3 mutation (Q178R).